EVOTEC NEUROSCIENCES

Evotec Neurosciences GmbH engages in the discovery and development of small molecule drugs.

#SimilarOrganizations #People #Financial #More

EVOTEC NEUROSCIENCES

Social Links:

Industry:
Biopharma Biotechnology Health Care Neuroscience

Founded:
1999-05-01

Address:
Hamburg, Hamburg, Germany

Country:
Germany

Total Employee:
11+

Status:
Active

Contact:
+49 40 560 81 0

Total Funding:
25 M EUR


Similar Organizations

galapagos-logo

Galapagos

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.

morria-biopharmaceuticals-logo

Morria Biopharmaceuticals

Morria Biopharmaceuticals engages in the discovery and development of multi-functional anti-inflammatory drugs.

Current Employees Featured

johannes-pohlner_image

Johannes Pohlner
Johannes Pohlner Co-Founder @ Evotec Neurosciences
Co-Founder

Founder


johannes-pohlner_image

Johannes Pohlner

Investors List

ventech-capital_image

Ventech

Ventech investment in Series A - Evotec Neurosciences

tvm-techno-venture-management_image

Techno Venture Management

Techno Venture Management investment in Series A - Evotec Neurosciences

star-ventures_image

Star Ventures

Star Ventures investment in Series A - Evotec Neurosciences

3i-plc_image

3i Plc

3i Plc investment in Series A - Evotec Neurosciences

mvm-life-science-partners_image

MVM Life Science Partners

MVM Life Science Partners investment in Series A - Evotec Neurosciences

More informations about "Evotec Neurosciences"

Evotec Neurosciences - Crunchbase Company Profile & Funding

Evotec Neurosciences GmbH engages in the discovery and development of small molecule drugs.See details»

Evotec Neurosciences - Products, Competitors, Financials, โ€ฆ

About Evotec Neurosciences Evotec Neurosciences discovers and develops therapeutics for the treatment of Alzheimer's disease and other Central Nervous System (CNS) disorders with high โ€ฆSee details»

Evotec - Wikipedia

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of โ‚ฌ7.5 billion and a pipeliโ€ฆSee details»

Evotec SE Profile | The Scientist

Mar 6, 2025 Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the โ€ฆSee details»

Evotec Achieves Further Progress in Neuroscience Collaboration โ€ฆ

Dec 16, 2022 Dr Cord Dohrmann, Chief Scientific Officer of Evotec, said: "We are delighted to see that after six years our neuroscience collaboration with Bristol Myers Squibb continues to โ€ฆSee details»

Together for Medicines That Matter - Evotec

Aug 6, 2025 Evotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that โ€ฆSee details»

Evotec - Crunchbase Company Profile & Funding

Evotec is a drug discovery alliance and development partnership rapidly progressing innovative product approaches with pharmaceutical and โ€ฆSee details»

Evotec SE Reports H1 2025 Results: Strong Progress on ... - BioSpace

22 minutes ago Evotec is a life science company that is pioneering the future of drug discovery and development. By integrating breakthrough science with AI-driven innovation and โ€ฆSee details»

About Us | Evotec

We are a life science company that is pioneering the future of drug discovery and development. By integrating breakthrough science with AI-driven innovation and advanced technologies, we โ€ฆSee details»

Evotec Announces Progress in Strategic Neuroscience Partnership โ€ฆ

Aug 8, 2024 Evotec and Bristol Myers Squibb entered their strategic neuroscience collaboration in December 2016 to identify disease-modifying treatments for a broad range of โ€ฆSee details»

Our Company | Evotec

Welcome to Evotec, where we are driven by a singular purpose: to be at the forefront of advancing medicine that truly matters. As a leading drug discovery and development โ€ฆSee details»

Evotec Neurosciences - Funding, Financials, Valuation & Investors

Evotec Neurosciences GmbH engages in the discovery and development of small molecule drugs.See details»

Evotec SE Reports H1 2025 Results: Strong Progress on Strategy โ€ฆ

8 hours ago About Evotec SE Evotec is a life science company that is pioneering the future of drug discovery and development. By integrating breakthrough science with AI-driven โ€ฆSee details»

Evotec Announces Key Progress in Neuroscience Collaboration โ€ฆ

Mar 6, 2025 Evotec SE today announced another major accomplishment in its long-standing neuroscience collaboration with Bristol Myers Squibb. The latest scientific achievement in the โ€ฆSee details»

Evotec Announces Key Progress in Neuroscience Collaboration โ€ฆ

Mar 4, 2025 Evotec SE announced another major accomplishment in its long-standing neuroscience collaboration with Bristol Myers Squibb triggering a research payment of US$20 m.See details»

Evotec Announces Key Progress in Neuroscience Collaboration โ€ฆ

Mar 4, 2025 Since the initiation of their strategic neuroscience collaboration in December 2016, Evotec and Bristol Myers Squibb have been working together to identify disease-modifying โ€ฆSee details»

Evotec Announces Key Progress in Neuroscience Collaboration โ€ฆ

Mar 4, 2025 Since the initiation of their strategic neuroscience collaboration in December 2016, Evotec and Bristol Myers Squibb have been working together to identify disease-modifying โ€ฆSee details»

Evotec Neurosciences and Takeda enter into drug discovery โ€ฆ

Evotec OAI leverages this discovery engine in providing assay development and screening through to compound optimisation and drug manufacturing services to a broad and well โ€ฆSee details»

Evotec SE reports H1 2025 results: Strong progress on strategy ...

Just โ€“ Evotec Biologics (โ€œJEBโ€; +16%) exceeding expectations driven by broadened customer base Key progress in collaborations with Bristol Myers Squibb (โ€œBMSโ€) on targeted protein โ€ฆSee details»

Evotec announces progress in strategic neuroscience partnership โ€ฆ

Aug 8, 2024 Evotec and Bristol Myers Squibb entered their strategic neuroscience collaboration in December 2016 to identify disease-modifying treatments for a broad range of โ€ฆSee details»

linkstock.net © 2022. All rights reserved